Summary:
This study is to see how well the medication works in helping treat volunteers with moderate to severely active Ulcerative Colitis who have previously failed a Biologic (medicine). The study is 24 weeks long-11 on-site visits.
Qualified Participants Must:
• 18-80 years old
• Confirmed diagnosis of Ulcerative Colitis
• Demonstrated intolerance or inadequate response to a biologic
• Currently not diagnosed with Crohn's disease, IBDU, radiation colitis, and Ischemic Colitis
Qualified Participants May Receive:
Qualified participants will receive compensation for each visit, medical care, and medication at no cost. We also provide complimentary transportation.